rfhg_231369.1

Basic information about the TSS

---

TSS ID: rfhg_231369.1 Species: human Chr: chr22		Start: 45740462 End: 45740484 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000464482.1:26 GeneID: 25814 HGNC/MGI_ID: HGNC:10549 UniProt_ID: Nearer transcript ids and distances:

Gene_name: ataxin 10 Gene_symbol: ATXN10 Gene_synonyms: ATX10 E46L FLJ37990 Gene_source: HGNC:10549

TATA-Box annotation

---

Distance to TSS:	-20051
Nearest PromoterID:	NR_039919
Entrez ID:	100616253
Nearest Unigene:
Nearest Refseq:	NR_039919
Nearest Ensembl:	ENSG00000264160
Gene Name:	ataxin 10
Gene Alias:	-
Gene Type:	ncRNA
CpG%:	0.000000
GC%:	0.434783
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ATXN10 p2@ATXN10 p3@ATXN10 p4@ATXN10
Sample		p1@ATXN10	p2@ATXN10	p3@ATXN10	p4@ATXN10
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	136.36	12.08	7.60	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	136.77	10.93	4.86	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	132.72	11.96	5.40	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	130.57	13.72	4.37	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	144.43	13.95	3.15	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	104.27	16.09	3.68	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	151.43	19.39	6.10	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	142.18	14.78	4.60	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	173.32	17.52	6.84	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	184.90	23.76	2.90	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	197.67	19.40	5.26	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	208.56	21.14	4.88	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	225.03	12.90	0.97	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	147.64	12.78	1.05	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	213.41	12.95	1.10	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	185.85	10.31	0.25	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	178.22	9.83	0.22	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	166.20	15.61	0.42	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	159.95	10.13	0.00	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	145.18	11.43	0.75	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	148.09	13.37	0.40	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	131.88	12.60	1.04	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	147.74	11.63	1.16	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	165.01	10.43	0.73	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	191.43	10.58	0.52	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	160.16	11.71	1.27	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	143.41	12.64	1.10	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	156.78	13.91	0.71	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	130.35	16.15	0.48	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	177.17	9.77	0.90	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	168.52	11.93	1.47	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	180.14	10.94	0.98	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	147.09	14.35	0.63	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	99.29	11.88	0.82	2.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	172.78	14.21	0.75	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	201.40	13.41	1.15	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	176.79	13.08	1.02	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	174.08	14.10	1.41	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	189.07	12.15	0.81	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	174.04	11.76	1.44	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	175.97	13.17	0.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	120.34	14.20	1.02	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	207.73	12.65	1.69	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	197.90	12.59	1.92	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	208.80	10.44	0.40	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	191.93	10.93	1.40	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	240.39	11.28	1.92	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	180.62	10.13	0.60	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	218.55	11.49	1.68	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	174.50	11.93	1.01	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	162.12	13.53	1.43	3.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	199.25	15.34	1.11	3.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	27.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	185.59	17.03	1.77	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	147.80	12.92	1.66	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	54.53	18.46	0.84	10.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	72.10	13.32	2.30	5.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	220.39	11.67	2.27	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	248.59	11.24	2.25	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	104.67	14.14	0.00	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	158.64	10.58	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	143.00	9.53	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	133.75	3.18	0.00	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	87.32	7.81	0.34	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	278.46	4.55	0.97	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	177.84	8.87	0.71	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	15.79	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	135.04	7.80	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	146.28	3.97	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	124.78	4.69	0.94	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	178.18	5.63	0.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	195.81	8.97	0.00	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	233.89	5.20	0.00	1.53
Adipocyte - breast, donor1	11376-118A8	63.04	19.32	0.63	0.00
Adipocyte - breast, donor2	11327-117E4	48.77	7.86	0.48	2.73
Adipocyte - omental, donor1	11473-119C6	72.27	10.94	0.51	0.38
Adipocyte - omental, donor2	11474-119C7	48.59	5.98	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	61.63	9.04	0.00	1.67
Adipocyte - perirenal, donor1	11476-119C9	56.78	8.93	0.64	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	26.39	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	38.39	11.29	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	53.52	5.91	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	87.62	13.49	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	63.57	7.21	1.03	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	78.61	16.45	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	84.06	12.34	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	89.04	9.73	0.16	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	59.71	7.10	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	41.59	8.53	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	65.66	7.79	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	71.53	6.65	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	50.74	8.04	0.00	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	61.52	7.53	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	70.64	2.74	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	61.66	5.30	0.44	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	26.18	0.72	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	26.36	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	57.03	5.94	1.44	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	46.86	6.69	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	52.59	2.47	0.82	0.00
Anulus Pulposus Cell, donor1	11248-116E6	62.71	14.30	0.34	0.34
Anulus Pulposus Cell, donor2	11463-119B5	86.70	12.98	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	64.25	14.83	0.00	2.25
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	58.61	13.46	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	64.21	14.98	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	55.60	14.05	1.49	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	59.44	13.91	2.53	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	58.75	15.84	1.98	2.64
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	56.21	9.75	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	58.74	18.45	0.97	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	68.89	17.22	1.19	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	54.61	13.18	0.75	2.64
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	60.23	13.79	0.73	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	66.45	15.05	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	80.23	21.25	3.79	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	57.32	15.01	2.73	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	83.99	21.56	3.62	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	65.90	15.00	1.61	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	80.30	17.38	1.89	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	78.05	18.44	2.41	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	53.65	15.61	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	72.15	14.60	1.99	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	75.65	15.61	2.40	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	74.34	10.62	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	72.21	15.27	1.54	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	67.12	8.39	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	52.91	15.53	1.46	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	60.71	15.94	2.66	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	59.36	15.75	0.00	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	53.58	12.54	1.71	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	62.64	18.17	1.71	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	67.88	13.94	0.77	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	66.16	17.83	1.88	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	73.63	12.54	3.22	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	69.92	8.56	2.14	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	49.14	18.13	0.58	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	72.86	18.97	0.90	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	102.17	16.63	0.00	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	48.82	20.85	0.51	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	66.22	12.73	1.27	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	69.89	17.15	1.27	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	55.24	10.79	0.86	2.16
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	79.59	15.45	1.91	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	72.50	14.79	1.16	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	45.35	13.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	69.67	17.80	1.19	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	55.59	18.53	2.32	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	95.07	19.01	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	74.19	17.80	2.36	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	69.19	21.06	4.81	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	64.15	10.93	2.19	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	60.00	14.71	3.22	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	43.36	20.40	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	86.95	27.20	2.54	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	73.91	18.17	2.48	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	82.01	11.63	2.14	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	66.92	17.69	1.91	2.87
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	70.96	15.74	2.22	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	62.56	19.84	1.53	4.58
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	59.27	18.28	1.66	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	71.76	22.51	1.59	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	79.23	19.99	2.91	1.45
Astrocyte - cerebellum, donor1	11500-119F6	71.97	1.72	1.35	0.37
Astrocyte - cerebellum, donor2	11580-120F5	99.96	2.74	1.20	0.68
Astrocyte - cerebellum, donor3	11661-122F5	47.40	2.10	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	128.63	11.85	2.09	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	155.63	11.97	2.26	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	219.71	12.98	5.97	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	75.81	8.95	0.69	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	85.44	8.90	1.00	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	65.77	8.53	1.02	0.23
Basophils, donor1	12241-129G9	7.85	8.63	0.00	0.00
Basophils, donor2	12242-129H1	14.79	24.89	0.00	0.00
Basophils, donor3	12243-129H2	21.90	18.82	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	34.28	4.10	0.86	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	20.57	0.91	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	21.52	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	38.29	10.04	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	51.16	4.37	2.29	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	37.54	4.15	0.69	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	38.87	13.68	0.72	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	145.72	55.44	3.19	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	175.61	33.07	3.96	1.86
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	90.18	31.34	0.96	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	41.37	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	18.60	23.11	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	17.82	14.66	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	24.81	15.59	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	37.93	14.72	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	36.01	14.03	0.76	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	46.68	12.16	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	14.02	17.92	0.14	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	13.58	17.80	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	23.22	23.93	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	6.19	10.88	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	10.49	9.11	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	9.92	9.17	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.29	10.18	0.00	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	11.75	10.50	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	9.79	18.50	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.62	8.66	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	10.03	16.90	0.00	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	16.64	13.31	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	8.33	13.68	0.00	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	9.58	17.56	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	9.16	29.77	0.00	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.86	11.67	0.00	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.11	12.67	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.24	13.53	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	11.03	9.41	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	15.18	15.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	21.46	22.30	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	5.88	7.35	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	10.22	7.05	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	11.85	9.21	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.24	9.24	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	7.43	7.81	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	8.62	23.06	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	15.56	6.55	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.95	10.66	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.96	13.46	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	24.41	62.99	0.00	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	20.33	62.14	0.00	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	24.48	56.54	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	36.59	33.32	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	27.94	42.61	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	33.00	28.76	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	13.78	65.32	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	13.61	79.48	0.66	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	18.32	80.85	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	69.10	10.16	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	60.34	19.66	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	68.35	22.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	81.55	26.12	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	70.76	21.44	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	65.28	17.55	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	85.49	22.75	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	69.87	13.18	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	71.51	12.33	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	55.13	13.78	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	45.94	10.60	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	31.11	71.92	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	29.56	61.92	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	39.16	12.05	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	25.28	12.36	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	95.07	28.18	1.13	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	80.72	34.95	0.68	0.00
CD4+ T Cells, donor1	11225-116C1	49.99	13.57	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	32.46	9.80	0.00	2.45
CD4+ T Cells, donor3	11382-118B5	50.93	15.55	0.30	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	51.81	16.59	0.51	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	63.34	20.21	0.00	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	60.94	16.10	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	59.26	28.92	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	53.38	44.25	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	75.81	32.96	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	47.98	16.33	0.14	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	78.80	16.61	0.17	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	70.29	13.22	0.16	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	53.80	26.90	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	59.05	33.54	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	47.96	22.44	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	53.13	21.08	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	92.25	20.98	0.21	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	92.22	17.04	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	85.39	25.02	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	109.87	26.80	0.00	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	77.11	26.90	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	63.97	25.96	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	67.58	27.94	0.22	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	68.93	22.91	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	54.61	22.25	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	64.99	31.19	0.87	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	59.71	27.89	0.44	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	67.80	31.18	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	62.78	35.08	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	65.60	37.69	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	60.92	34.06	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	60.61	29.94	0.74	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	64.68	30.80	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	60.88	34.74	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	60.94	36.01	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	41.58	21.28	0.33	0.33
CD8+ T Cells, donor2	11307-117C2	31.16	10.14	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	51.26	13.13	0.25	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	133.05	11.47	0.92	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	113.11	10.06	0.72	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	106.97	7.39	0.27	3.28
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	71.15	12.31	1.50	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	104.63	8.88	1.44	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	110.96	10.00	0.91	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	127.33	11.95	1.96	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	143.18	10.53	0.53	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	121.24	9.38	1.17	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	116.83	6.34	1.51	1.81
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	118.24	4.65	1.16	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	123.36	10.92	1.60	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	97.18	10.07	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	117.96	7.29	0.91	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	159.62	3.73	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	123.53	9.72	1.08	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	120.27	8.63	1.44	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	110.31	6.13	1.41	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	106.48	12.68	4.12	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	138.10	10.46	1.85	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	122.14	8.01	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	110.15	9.56	1.91	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	120.60	13.79	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	105.14	8.32	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	130.88	12.85	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	143.38	6.99	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	123.22	5.01	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	162.67	27.42	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	54.84	12.35	0.49	1.98
Cardiac Myocyte, donor3	11686-122I3	95.76	13.15	1.37	0.11
Chondrocyte - de diff, donor1	11261-116G1	88.05	17.68	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	54.73	8.88	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	68.72	18.77	0.80	0.68
Chondrocyte - re diff, donor2	11339-117F7	79.68	9.85	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	71.18	7.68	0.81	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	111.09	11.25	0.80	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	107.10	8.12	1.07	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	130.18	9.47	1.95	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	95.28	10.45	0.64	0.09
Corneal Epithelial Cells, donor1	11526-119I5	27.45	3.51	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	31.85	12.51	3.41	0.00
Corneal Epithelial Cells, donor3	11687-122I4	45.50	3.58	2.05	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	46.72	10.40	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	41.00	7.57	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	43.30	7.24	0.00	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	56.37	15.72	0.68	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	51.58	21.54	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	42.59	13.55	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	43.19	4.67	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	42.25	3.52	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	46.66	2.26	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	62.52	4.33	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	44.79	2.33	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	66.11	3.76	0.00	1.65
Endothelial Cells - Artery, donor3	11413-118E9	50.49	4.03	0.00	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	61.84	5.98	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	66.94	7.91	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	62.02	6.77	0.56	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	34.76	3.27	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	45.30	4.17	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	33.32	2.84	0.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	60.82	4.80	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	40.36	1.05	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	71.19	11.18	0.75	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	84.30	4.13	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	108.08	5.01	0.37	0.00
Endothelial Cells - Vein, donor1	11267-116G7	45.50	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	30.04	7.68	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	58.25	5.50	0.47	0.00
Eosinophils, donor1	12244-129H3	0.00	60.99	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	32.74	1.95	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	41.60	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	92.78	6.98	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	89.67	14.78	2.85	2.30
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	126.65	16.79	1.19	2.93
Fibroblast - Aortic Adventitial, donor1	11245-116E3	88.29	20.74	3.27	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	141.93	22.93	7.51	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	91.13	15.61	2.43	1.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	79.57	11.33	0.79	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	97.33	16.61	1.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	113.41	12.70	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	37.90	4.55	0.00	3.03
Fibroblast - Cardiac, donor3	11417-118F4	44.63	5.52	0.95	0.47
Fibroblast - Cardiac, donor4	11452-119A3	100.63	20.01	0.61	0.30
Fibroblast - Cardiac, donor5	11456-119A7	80.84	7.87	0.51	0.38
Fibroblast - Cardiac, donor6	11460-119B2	89.29	9.55	0.91	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	55.74	2.55	0.40	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	69.46	7.33	0.86	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	92.28	2.93	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	65.73	2.77	1.38	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	65.81	24.25	0.85	0.34
Fibroblast - Dermal, donor1	11269-116G9	78.89	19.25	0.70	0.00
Fibroblast - Dermal, donor2	11346-117G5	52.83	8.96	1.42	0.00
Fibroblast - Dermal, donor3	11418-118F5	73.98	26.47	1.33	0.24
Fibroblast - Dermal, donor4	11450-119A1	93.71	10.85	1.13	0.90
Fibroblast - Dermal, donor5	11454-119A5	104.67	14.31	0.52	0.70
Fibroblast - Dermal, donor6	11458-119A9	115.81	11.04	2.11	0.81
Fibroblast - Gingival, donor1	11237-116D4	75.38	19.37	1.87	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	147.51	26.72	3.14	0.26
Fibroblast - Gingival, donor2	11318-117D4	94.49	13.57	2.50	0.79
Fibroblast - Gingival, donor3	11394-118C8	75.42	12.38	0.29	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	83.11	18.70	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	93.92	17.97	1.23	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	158.08	26.81	3.90	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	114.67	24.21	2.30	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	246.66	6.70	3.53	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	153.41	19.60	3.22	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	105.13	25.77	3.27	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	156.42	20.07	3.95	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	96.99	17.61	0.29	0.73
Fibroblast - Lung, donor1	11270-116H1	40.78	6.80	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	74.61	13.43	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	84.20	9.07	0.84	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	66.64	4.17	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	58.74	5.59	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	26.59	1.68	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	89.31	8.93	1.62	0.00
Fibroblast - Mammary, donor2	11620-122A9	43.94	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	59.56	5.96	11.91	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	86.90	13.38	2.52	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	107.85	11.83	0.76	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	89.04	21.73	1.84	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	120.59	20.61	1.14	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	97.20	21.06	1.35	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	112.61	11.60	0.93	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	76.16	12.38	1.88	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	90.01	5.89	2.84	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	58.13	2.00	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	89.75	17.00	1.19	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	90.69	21.23	3.18	2.18
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	66.96	25.75	0.71	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	88.49	23.45	2.17	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	106.80	19.86	2.11	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	77.29	23.53	1.51	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	136.15	28.85	4.56	1.27
Fibroblast - skin normal, donor1	11553-120C5	92.70	41.35	4.27	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	101.06	25.46	1.80	0.20
Fibroblast - skin normal, donor2	11561-120D4	78.56	29.74	2.31	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	125.13	24.18	2.12	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	84.17	24.85	0.75	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	76.41	43.42	6.50	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	94.92	20.03	0.99	2.30
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	87.13	26.74	2.13	0.96
Fibroblast - skin walker warburg, donor1	11554-120C6	101.88	35.09	6.07	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	53.48	33.25	2.82	2.51
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	110.80	0.00	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	52.29	32.25	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	53.05	24.62	4.68	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	57.51	20.30	3.90	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	68.99	15.08	3.32	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	246.51	15.31	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	224.60	8.93	2.55	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	162.32	5.42	0.29	3.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	438.45	6.62	1.38	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	298.19	14.61	2.51	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	280.16	5.35	1.39	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	398.62	7.67	1.32	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	387.46	30.01	2.61	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	164.06	4.86	0.88	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	126.34	7.77	1.41	1.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	131.27	9.73	1.11	1.72
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	135.66	6.72	1.07	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	122.90	6.44	1.12	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	122.51	6.37	0.28	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	104.50	4.68	1.02	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	117.28	7.53	1.14	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	99.15	6.73	1.12	1.74
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	135.08	3.28	1.31	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	128.83	8.27	1.48	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	115.72	10.33	1.43	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	134.95	6.70	0.89	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	119.57	12.50	2.02	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	103.82	15.10	1.70	1.36
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	124.32	11.26	2.04	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	130.59	15.30	1.77	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	105.03	14.86	1.20	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	105.34	14.50	1.44	1.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	108.07	12.90	1.66	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	96.37	13.27	2.04	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	115.53	13.62	1.03	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	104.92	14.53	1.96	1.50
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	100.56	15.01	2.33	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	123.66	11.90	1.54	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	103.68	15.50	3.32	1.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	109.41	12.16	1.46	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	125.72	9.62	1.28	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	94.75	13.08	1.90	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	95.70	13.13	2.69	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	112.51	14.29	2.13	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	95.13	14.22	1.78	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	98.58	10.10	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	108.57	9.26	1.40	1.68
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	74.16	13.52	3.15	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	87.44	13.10	1.87	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	89.97	12.24	2.75	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	74.48	13.60	2.85	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	98.67	11.39	1.90	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	96.05	11.61	2.58	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	75.00	15.57	2.19	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	152.73	16.86	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	79.02	12.53	1.98	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	79.49	10.69	2.02	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	94.29	12.96	0.51	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	118.64	5.57	1.19	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	122.03	5.39	1.23	1.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	148.94	7.57	1.43	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	158.66	10.95	1.88	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	153.43	9.04	1.70	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	169.72	9.22	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	146.01	9.90	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	150.47	14.31	1.55	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	189.33	4.81	3.21	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	203.44	12.17	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	143.54	8.14	1.30	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	124.36	9.88	2.06	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	203.27	10.00	0.00	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	138.71	7.83	0.28	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	154.27	7.52	2.29	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	168.61	6.71	2.52	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	155.54	9.86	1.59	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	136.54	5.77	2.04	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	127.38	10.44	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	160.93	11.45	1.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	134.38	6.81	1.18	1.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	145.70	18.64	1.69	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	142.49	14.08	2.90	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	159.02	14.04	3.22	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	189.67	21.07	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	127.62	13.45	2.31	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	126.80	12.06	1.30	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	179.25	16.05	2.01	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	122.90	11.17	0.00	2.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	173.57	11.64	3.42	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	178.90	2.48	2.48	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	187.80	14.16	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	152.08	8.45	0.00	4.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	199.40	10.17	2.54	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	151.56	11.57	1.20	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	141.10	7.89	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	169.98	5.90	0.00	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	159.86	7.58	2.33	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	126.84	8.34	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	119.52	11.02	2.54	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	108.04	10.15	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	93.17	17.47	1.46	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	62.77	17.12	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	53.22	9.56	2.08	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	66.34	29.24	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	56.45	23.79	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	53.47	30.08	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	123.00	52.22	19.26	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	136.90	62.79	27.01	2.03
Hep-2 cells mock treated, biol_rep3	11900-125F1	122.17	49.37	19.79	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	121.44	51.27	21.21	1.20
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	139.69	59.75	22.14	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	115.39	50.38	18.51	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	120.80	49.94	18.68	2.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	123.86	54.04	23.33	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	103.48	46.13	15.70	2.88
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	61.56	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	44.58	0.00	1.30	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	50.23	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	70.19	3.88	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	50.13	1.45	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	61.72	11.89	0.52	0.35
Hepatocyte, donor1	11523-119I2	112.59	6.05	0.00	0.00
Hepatocyte, donor2	11603-120I1	116.35	9.70	2.15	0.00
Hepatocyte, donor3	11684-122I1	115.96	6.75	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	175.57	50.26	3.92	3.26
Intestinal epithelial cells (polarized), donor1	11246-116E4	70.09	4.19	2.27	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	78.35	7.41	1.23	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	60.49	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	58.14	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	58.95	5.13	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	50.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	43.35	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	51.62	2.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	39.91	2.22	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	68.10	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	36.53	2.52	1.26	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	35.57	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	41.99	2.58	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	57.96	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	51.34	1.63	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	34.00	2.10	0.42	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	34.56	1.61	0.00	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	57.24	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	35.87	2.36	0.94	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	32.65	1.81	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	44.12	2.15	1.08	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	54.63	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	41.45	4.46	1.28	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	34.63	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	52.13	1.43	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	37.04	1.54	1.23	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	50.92	3.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	50.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	57.72	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	33.20	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	41.85	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	29.25	4.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	6.97	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	34.14	3.20	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	44.33	1.39	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	45.59	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	32.21	1.84	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	6.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	55.88	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	37.01	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	42.68	11.59	2.53	0.24
Keratinocyte - epidermal, donor2	11349-117G8	31.04	8.20	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	61.15	15.43	3.22	0.57
Keratinocyte - oral, donor1	11251-116E9	95.01	34.06	3.06	0.45
Keratocytes, donor1	11527-119I6	78.05	2.41	0.69	0.00
Keratocytes, donor2	11607-120I5	53.90	1.17	1.17	0.00
Keratocytes, donor3	11688-122I5	92.48	8.10	0.59	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	147.26	6.59	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	90.61	7.55	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	104.38	6.11	2.88	0.00
Lens Epithelial Cells, donor3	11690-122I7	91.02	5.35	1.01	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	46.72	6.17	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	45.77	3.07	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	44.55	4.72	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	39.79	1.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	44.75	3.78	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	30.83	3.56	0.22	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	42.68	4.51	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	28.82	2.78	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	31.39	2.25	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	34.41	5.93	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	38.97	4.85	0.19	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	23.51	2.04	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	41.11	3.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	46.04	2.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	29.53	2.75	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	42.81	4.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	30.86	3.12	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	35.87	2.20	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	36.86	3.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	34.27	2.93	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	23.65	3.24	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	39.28	4.85	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	44.43	2.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	35.57	3.78	0.15	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	26.96	4.67	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	56.74	3.77	0.21	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	37.29	2.56	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	27.52	3.44	0.00	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	44.03	3.39	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	25.55	2.33	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	41.67	5.33	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	32.42	2.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	32.09	2.11	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	48.13	4.81	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	40.03	4.69	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	28.87	2.89	0.14	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	48.25	5.15	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	49.00	5.48	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	42.83	2.80	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	38.76	5.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	33.45	3.39	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	26.30	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	34.38	3.94	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	38.22	2.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	24.48	1.65	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	42.94	3.96	0.37	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	25.36	2.56	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	30.43	2.39	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	29.46	13.60	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	23.78	16.88	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	23.01	8.16	2.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	32.16	12.27	0.85	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	28.13	7.03	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	36.42	12.14	0.93	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	26.28	9.79	1.55	4.64
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	32.12	21.41	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	30.08	14.48	1.36	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	31.12	13.96	1.16	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	31.96	8.55	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	36.72	13.96	1.90	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	40.57	9.24	1.54	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	29.64	11.29	2.47	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	29.98	8.66	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	29.03	11.21	1.53	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	30.15	13.61	1.87	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	33.25	8.88	1.51	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	38.65	11.66	1.84	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	40.77	9.79	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	30.61	10.00	0.83	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	36.71	9.53	1.12	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	32.97	10.30	3.09	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	31.64	8.71	3.19	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	38.86	13.15	1.20	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	28.77	7.75	1.11	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	33.23	12.37	2.12	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	27.66	11.06	2.21	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	28.78	6.91	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	31.85	8.44	1.92	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	36.23	7.93	0.00	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	32.82	10.67	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	32.08	10.39	1.36	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	26.57	10.77	2.15	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	31.37	15.68	2.24	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	31.59	9.29	1.11	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	29.29	13.78	2.58	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	44.53	8.56	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	35.32	7.66	1.67	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	27.75	9.05	3.02	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	35.55	9.95	2.13	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	25.78	7.22	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	36.50	9.66	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	28.28	4.71	2.02	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	29.63	9.63	1.85	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	23.26	13.96	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	27.50	10.58	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	34.01	8.40	2.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	33.44	21.08	3.63	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	40.63	13.03	1.53	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	30.58	9.37	1.48	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.99	17.88	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	35.20	10.06	1.51	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	36.95	10.36	0.45	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	30.98	8.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	32.96	13.81	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	40.28	8.21	1.96	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	38.26	11.88	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	34.25	15.57	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	28.44	12.69	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	36.34	11.74	1.68	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	34.89	10.16	1.32	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	35.10	10.03	1.16	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	35.44	9.11	0.00	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	41.33	14.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	33.00	13.12	0.40	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	33.42	10.33	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	22.13	9.68	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	31.16	13.68	0.76	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	40.28	8.26	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	32.65	6.05	2.42	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	30.11	9.51	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	36.25	14.39	2.13	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	24.71	8.62	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	37.54	10.28	1.03	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	45.98	11.32	2.12	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	18.73	7.94	0.57	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	41.19	7.07	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	35.24	10.96	1.57	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	34.24	9.60	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	32.52	9.29	1.86	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	28.77	8.03	2.01	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	29.41	9.62	0.53	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	36.77	11.72	1.21	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	39.46	10.10	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	27.56	10.67	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	27.92	5.70	1.71	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	42.18	9.97	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	33.92	3.83	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	39.20	7.57	0.89	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	40.81	8.58	0.78	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	42.44	11.27	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	43.65	14.55	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	25.75	10.71	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	26.79	9.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	37.49	10.22	0.26	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	57.35	39.30	4.25	0.00
Mallassez-derived cells, donor2	11929-125I3	64.33	24.24	3.01	0.00
Mallassez-derived cells, donor3	11930-125I4	58.79	21.40	6.12	0.14
Mammary Epithelial Cell, donor1	11273-116H4	77.22	21.42	2.69	0.10
Mammary Epithelial Cell, donor2	11350-117G9	67.75	20.85	4.34	0.00
Mammary Epithelial Cell, donor3	11422-118F9	44.65	8.98	3.49	0.00
Mast cell - stimulated, donor1	11487-119E2	61.01	71.18	0.00	0.00
Mast cell, donor1	11563-120D6	79.38	33.42	0.54	0.22
Mast cell, donor2	11565-120D8	50.82	26.45	0.59	0.00
Mast cell, donor3	11566-120D9	46.15	26.11	0.68	0.00
Mast cell, donor4	11567-120E1	45.21	24.29	0.18	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	79.18	44.69	0.22	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	107.40	66.54	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	78.58	46.00	0.69	0.34
Mast cell, expanded, donor8	11941-126A6	75.65	47.70	0.50	0.33
Melanocyte - dark, donor1	11502-119F8	54.23	4.78	0.50	0.20
Melanocyte - dark, donor2	11582-120F7	63.33	14.54	1.04	1.04
Melanocyte - dark, donor3	11663-122F7	51.72	20.50	2.68	0.22
Melanocyte - light, donor1	11274-116H5	24.21	5.41	0.71	0.00
Melanocyte - light, donor2	11351-117H1	29.35	4.09	0.00	0.00
Melanocyte - light, donor3	11423-118G1	34.69	3.47	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	54.25	16.04	2.29	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	46.80	12.37	2.42	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	64.29	13.93	2.68	1.07
Meningeal Cells, donor1	11493-119E8	73.94	2.85	0.37	0.00
Meningeal Cells, donor2	11573-120E7	136.01	3.08	0.44	0.00
Meningeal Cells, donor3	11654-122E7	89.16	10.43	1.30	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	118.05	19.96	3.71	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	66.22	9.66	1.11	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	18.40	5.26	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	24.86	5.23	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	83.24	16.50	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	89.58	20.33	2.12	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	153.31	26.64	5.53	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	71.42	3.30	1.32	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	96.44	2.92	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	54.22	2.25	1.23	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	59.14	18.84	0.28	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	30.85	2.23	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	88.42	13.95	0.66	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	26.11	4.45	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	28.03	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	89.66	1.92	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	82.23	16.30	1.06	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	71.61	13.76	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	98.69	10.89	1.45	1.45
Mesothelial Cells, donor1	11247-116E5	115.62	13.79	3.71	0.53
Mesothelial Cells, donor2	12156-128G5	69.56	11.01	6.01	0.50
Mesothelial Cells, donor3	11402-118D7	116.20	11.35	2.31	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	40.51	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	48.76	6.90	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	57.12	9.13	0.00	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	39.98	9.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	42.73	7.47	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	4.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	41.54	7.26	0.50	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	65.17	4.65	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	116.80	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	40.44	7.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	59.00	6.73	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	24.78	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	36.85	9.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	18.42	5.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	29.92	9.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	41.44	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	32.79	4.17	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	51.98	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	24.84	9.53	0.50	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	35.65	8.32	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	22.67	2.21	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	23.02	5.07	0.00	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	42.28	6.10	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	27.11	4.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	28.10	7.29	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	39.12	5.33	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	20.15	4.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	49.68	3.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	26.51	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	29.90	4.08	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	40.29	7.35	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	22.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	17.78	9.61	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	38.42	5.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	42.51	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	18.52	7.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	44.85	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	22.33	6.57	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	23.18	4.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	40.34	3.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	23.55	6.69	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	27.84	3.48	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	46.41	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	23.25	5.81	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	41.14	4.38	0.00	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	40.84	1.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	30.86	5.61	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	36.99	2.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	48.95	2.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	24.74	4.52	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	32.97	5.84	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	23.09	5.54	0.00	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	37.56	6.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	27.64	0.69	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	21.25	4.15	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	38.18	3.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	40.02	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	34.70	3.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	38.31	5.69	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	24.01	2.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	23.25	3.50	0.32	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	32.06	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	32.23	3.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	21.31	5.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	24.58	9.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	33.24	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	24.70	5.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	32.58	3.46	0.29	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	18.55	2.47	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.76	3.87	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	18.83	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	19.60	16.04	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	36.80	12.81	0.33	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	28.40	6.31	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	30.44	11.86	0.00	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	42.84	23.28	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	37.18	16.15	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	33.29	9.06	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	18.89	10.63	0.23	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	24.31	10.31	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	41.04	8.06	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	34.22	7.78	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	16.57	12.29	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	24.24	9.09	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	22.77	10.12	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	9.53	16.34	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	6.99	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	9.72	13.77	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	6.04	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	28.55	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	16.31	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	14.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	82.73	13.57	1.72	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	76.30	6.27	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	296.36	6.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	300.09	7.93	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	206.30	7.04	0.57	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	252.14	11.17	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	207.38	7.48	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	34.92	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	269.12	7.12	2.09	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	309.38	15.11	2.09	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	253.47	7.03	1.35	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	178.49	10.72	0.84	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	190.60	9.43	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	140.75	5.68	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	257.06	15.64	4.08	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	336.56	8.82	1.47	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	124.84	10.57	0.91	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	225.44	12.20	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	217.31	3.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	97.14	5.58	0.33	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	298.58	14.47	1.30	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	150.98	8.47	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	232.07	12.66	0.70	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	198.13	6.44	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	221.41	7.07	1.61	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	116.23	15.86	1.38	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	70.80	5.06	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	153.05	6.24	0.67	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	243.03	8.47	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	167.57	5.70	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	210.33	6.44	1.29	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	72.22	27.08	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	197.27	7.66	1.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	203.34	3.61	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	197.21	5.56	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	180.16	11.14	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	147.94	7.95	1.14	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	224.54	7.50	2.28	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	234.02	4.36	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	156.49	5.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	210.78	2.65	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	166.21	8.64	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	222.23	4.46	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	237.35	5.74	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	136.10	8.47	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	113.16	7.07	0.44	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	174.84	11.52	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	204.24	8.54	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	204.89	5.67	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	200.96	5.15	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	155.06	10.28	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	108.83	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	40.46	10.12	0.00	5.06
Myoblast, donor1	11241-116D8	71.93	21.37	1.86	0.87
Myoblast, donor2	11322-117D8	107.79	16.69	1.73	2.30
Myoblast, donor3	11398-118D3	104.60	20.01	2.02	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	84.79	26.56	1.61	0.15
Natural Killer Cells, donor1	11230-116C6	46.74	15.38	0.92	0.31
Natural Killer Cells, donor2	11311-117C6	31.36	11.46	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	39.57	12.88	0.00	0.55
Neural stem cells, donor1	11275-116H6	159.69	9.07	0.73	1.09
Neural stem cells, donor2	11352-117H2	177.16	13.48	1.93	1.93
Neurons, donor1	11494-119E9	190.03	13.65	4.55	2.28
Neurons, donor2	11574-120E8	186.48	14.31	2.64	0.44
Neurons, donor3	11655-122E8	283.65	10.69	4.93	1.64
Neutrophils, donor1	11233-116C9	0.93	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	3.05	1.22	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	75.04	18.64	0.59	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	72.61	9.12	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	82.03	9.23	0.20	0.60
Olfactory epithelial cells, donor1	11933-125I7	124.44	23.26	4.82	0.69
Olfactory epithelial cells, donor2	11934-125I8	124.92	24.17	3.33	2.75
Olfactory epithelial cells, donor3	11935-125I9	142.56	23.27	4.65	0.68
Olfactory epithelial cells, donor4	11936-126A1	176.78	18.99	3.21	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	95.69	9.03	1.81	0.00
Osteoblast - differentiated, donor1	11276-116H7	40.62	11.91	1.28	0.00
Osteoblast - differentiated, donor2	11353-117H3	33.15	4.57	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	45.31	9.93	0.62	0.62
Osteoblast, donor1	11277-116H8	54.72	6.06	0.59	0.20
Osteoblast, donor2	11354-117H4	101.84	19.66	2.81	0.00
Osteoblast, donor3	11426-118G4	100.60	10.84	1.42	0.18
Pancreatic stromal cells, donor1	11249-116E7	78.00	34.54	2.95	1.26
Pericytes, donor1	11491-119E6	24.14	0.78	0.00	0.00
Pericytes, donor2	11571-120E5	45.50	0.68	0.45	0.00
Pericytes, donor3	11652-122E5	67.34	3.87	0.20	0.20
Perineurial Cells, donor1	11499-119F5	85.33	7.23	0.57	0.23
Perineurial Cells, donor2	11579-120F4	78.85	15.09	0.83	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	50.68	26.77	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	37.22	22.28	0.24	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	45.42	19.41	0.26	0.13
Placental Epithelial Cells, donor1	11278-116H9	31.09	4.07	2.15	0.00
Placental Epithelial Cells, donor2	11355-117H5	33.27	13.31	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	36.91	6.87	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	49.68	7.91	0.63	0.63
Preadipocyte - breast, donor1	11467-119B9	59.65	13.13	0.75	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	76.88	7.96	1.04	0.13
Preadipocyte - breast, donor2	11328-117E5	54.94	7.66	0.90	1.58
Preadipocyte - omental, donor1	11468-119C1	69.69	13.75	0.96	0.32
Preadipocyte - omental, donor2	11329-117E6	74.64	13.53	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	86.81	9.60	1.86	0.43
Preadipocyte - perirenal, donor1	11469-119C2	55.12	7.87	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	51.29	9.21	1.84	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	102.53	15.94	1.42	2.30
Preadipocyte - subcutaneous, donor3	11428-118G6	101.83	18.22	0.68	1.19
Preadipocyte - visceral, donor1	11280-116I2	92.87	20.31	1.40	0.37
Preadipocyte - visceral, donor2	11357-117H7	79.61	10.12	0.46	1.84
Preadipocyte - visceral, donor3	11429-118G7	77.64	12.75	1.04	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	80.86	5.28	1.81	0.30
Prostate Epithelial Cells, donor2	11331-117E8	72.45	17.06	5.01	0.41
Prostate Epithelial Cells, donor3	11404-118D9	38.89	5.08	0.98	0.37
Prostate Stromal Cells, donor1	11254-116F3	100.69	27.56	2.16	1.14
Prostate Stromal Cells, donor2	11332-117E9	124.97	16.50	2.69	1.43
Prostate Stromal Cells, donor3	11405-118E1	96.25	22.84	1.67	2.09
Renal Cortical Epithelial Cells, donor1	11516-119H4	49.64	2.19	1.46	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	100.57	10.74	1.52	0.14
Renal Epithelial Cells, donor1	11517-119H5	52.24	1.01	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	81.80	4.98	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	119.84	10.59	1.59	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	28.60	2.04	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	57.81	1.21	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	107.01	10.43	0.89	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.29	2.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	79.45	3.96	1.76	0.44
Renal Mesangial Cells, donor2	11598-120H5	90.91	1.88	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	44.11	1.94	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	101.73	3.76	1.07	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	45.96	2.11	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	100.09	5.01	3.66	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	149.35	12.19	1.04	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	92.38	1.71	1.14	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	51.46	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	94.34	10.04	0.50	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	74.57	7.48	0.94	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	89.34	4.47	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	42.38	16.51	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	52.78	4.64	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	59.94	4.55	0.26	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	87.29	3.67	0.60	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	90.35	8.25	1.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	56.19	7.32	0.74	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	79.95	3.61	0.70	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	91.07	6.01	1.16	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	77.22	4.24	0.41	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	72.46	4.39	0.45	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	75.62	9.14	1.25	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	71.73	5.45	0.43	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	71.90	5.15	0.64	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	88.07	6.64	1.11	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	83.16	4.01	0.76	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	91.67	6.15	1.02	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	86.06	11.84	1.13	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	86.26	3.98	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	82.35	5.45	0.78	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	81.35	6.30	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	72.73	4.91	0.32	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	81.01	5.61	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	85.11	5.81	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	101.01	4.74	0.73	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	82.90	6.87	0.49	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	92.55	6.72	0.81	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	67.70	4.72	0.00	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	88.69	5.95	0.79	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	87.46	7.72	0.70	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	80.45	7.05	0.62	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	78.09	6.19	0.22	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	107.78	7.94	2.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	84.25	6.19	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	111.03	4.09	0.68	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	99.48	7.52	0.58	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	76.34	7.39	1.20	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	111.11	6.58	1.10	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	91.11	7.72	0.66	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	87.26	4.43	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	86.56	4.14	0.59	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	87.70	5.86	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	70.10	6.36	0.14	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	82.62	5.95	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	102.99	6.65	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	65.83	5.37	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	91.88	12.93	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	90.06	8.76	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	80.41	6.98	0.49	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	134.05	27.51	0.87	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	96.74	14.60	1.83	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	85.60	7.53	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	105.40	9.50	0.68	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	109.03	10.18	1.50	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	49.12	10.15	0.35	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	111.20	10.67	1.07	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	122.60	7.81	0.60	0.00
Schwann Cells, donor1	11498-119F4	56.99	2.44	0.75	0.00
Schwann Cells, donor2	11578-120F3	91.87	10.21	3.40	0.00
Schwann Cells, donor3	11659-122F3	79.31	16.65	1.31	0.44
Sebocyte, donor1	11220-116B5	57.52	12.60	7.12	0.55
Sebocyte, donor2	11301-117B5	46.87	9.19	1.38	0.00
Sebocyte, donor3	11378-118B1	42.25	7.01	1.65	0.21
Sertoli Cells, donor1	11255-116F4	99.40	18.22	0.00	0.00
Sertoli Cells, donor2	11333-117F1	81.91	22.59	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	65.81	6.42	0.35	0.44
Skeletal Muscle Cells, donor2	11358-117H8	23.13	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	74.41	9.20	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	102.27	8.17	0.63	0.63
Skeletal Muscle Cells, donor5	11455-119A6	101.67	11.59	0.74	0.74
Skeletal Muscle Cells, donor6	11459-119B1	117.74	9.54	0.62	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	83.79	21.04	0.50	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	94.75	15.84	0.43	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	122.62	12.00	1.29	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	90.23	8.93	0.42	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	52.11	3.62	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	61.09	6.19	0.28	0.69
Skin - palm, donor1	10286-104F7	59.09	24.17	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	80.44	14.56	2.88	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	142.31	31.08	6.54	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	92.05	11.55	1.56	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	52.13	15.85	3.20	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	60.34	9.00	0.84	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	123.91	36.37	5.50	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	52.02	5.62	1.35	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	94.12	22.53	1.54	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	92.27	11.78	1.78	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	71.71	15.87	2.35	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	49.28	11.49	0.66	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	58.67	7.48	1.18	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	97.34	18.54	5.41	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	75.06	15.01	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	75.59	13.44	3.59	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	71.15	12.41	0.44	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	88.85	12.55	3.71	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	75.86	10.09	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	113.70	10.63	0.89	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	98.66	9.82	0.57	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	52.71	1.14	0.65	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	86.15	11.57	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	57.08	12.63	1.26	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	6.12	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	56.27	6.68	1.91	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	92.91	17.11	0.59	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	95.35	11.41	1.29	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	98.87	13.33	1.05	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	62.34	7.42	1.86	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	75.45	8.62	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	80.39	5.08	1.20	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	59.06	1.37	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	82.93	17.67	0.55	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	140.19	31.10	3.22	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	84.19	7.05	1.37	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	51.93	7.25	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	101.20	9.80	1.85	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	117.58	22.64	2.53	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	115.33	14.65	2.38	2.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	35.26	15.73	0.51	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	94.23	17.79	1.81	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	39.76	6.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	36.18	47.81	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	75.34	11.16	2.79	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	89.87	21.71	5.05	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	88.06	12.22	4.70	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	43.95	1.77	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	92.55	13.00	0.75	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	90.16	9.81	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	62.03	6.62	1.87	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	64.76	11.22	1.53	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	56.22	5.64	1.13	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	93.77	18.17	1.54	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	134.65	21.78	2.60	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	27.14	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	52.11	5.38	0.73	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	133.45	21.87	4.42	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	64.66	17.85	1.17	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	71.72	14.19	0.00	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	79.34	16.40	1.32	1.85
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	32.36	13.76	0.74	2.23
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	90.55	15.45	2.16	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	98.80	11.92	1.70	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	70.11	24.03	0.39	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	47.23	14.98	0.76	2.79
Smooth muscle cells - airway, control, donor2	11967-126D5	75.47	5.59	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	61.86	8.36	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	82.50	17.88	0.46	1.38
Synoviocyte, donor1	11291-117A4	68.00	15.99	1.18	0.17
Synoviocyte, donor2	11368-117I9	72.25	21.29	1.01	0.67
Synoviocyte, donor3	11440-118H9	56.97	20.55	0.45	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	66.46	6.43	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	49.55	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	51.40	2.78	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	39.28	9.25	1.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	32.47	7.73	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	37.22	5.73	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	72.83	8.49	0.25	0.00
Urethra, donor2	10319-105A4	257.18	23.38	5.40	1.80
Urothelial Cells, donor1	11520-119H8	44.10	1.59	1.06	0.27
Urothelial Cells, donor2	11600-120H7	38.05	0.80	0.40	0.40
Urothelial Cells, donor3	11681-122H7	29.34	1.15	0.46	0.00
Urothelial cells, donor0	11216-116B1	74.89	12.93	0.89	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	42.71	34.70	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	31.45	21.44	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	37.65	11.64	0.00	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	31.68	21.69	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	51.13	23.82	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	33.32	20.82	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	31.20	28.45	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	40.17	12.78	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	183.19	6.66	1.73	1.36
Wilms' tumor cell line:HFWT	10597-108E3	156.65	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	167.59	30.17	9.78	0.56
achilles tendon, donor2	10292-104G4	51.66	14.47	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	136.91	13.26	0.76	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	115.16	13.23	1.16	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	150.28	48.67	1.42	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	125.99	33.47	0.82	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	83.76	13.77	0.00	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	84.17	42.93	1.69	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	91.74	36.20	0.82	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	126.46	23.79	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	130.68	24.50	1.23	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	162.31	41.55	1.55	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	67.16	20.24	0.37	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	159.92	66.31	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	132.46	32.07	1.63	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	109.52	39.09	1.55	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	123.33	30.39	0.88	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	163.13	40.90	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	123.79	15.63	0.82	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	180.18	24.56	1.53	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	108.38	26.88	2.99	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	93.41	30.03	1.21	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	103.74	32.25	1.20	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	117.38	24.95	0.67	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	161.10	6.67	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	286.16	7.43	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	107.72	18.08	1.13	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	165.29	24.86	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	161.20	13.12	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	100.79	12.48	1.18	0.00
adipose tissue, adult, pool1	10010-101C1	42.66	12.25	0.47	0.16
adipose, donor1	10184-103D4	80.34	11.73	0.00	3.52
adipose, donor2	10185-103D5	355.64	8.92	0.81	0.00
adipose, donor3	10186-103D6	256.77	16.07	3.81	1.36
adipose, donor4	10187-103D7	121.35	0.87	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	95.48	3.16	1.10	0.16
adrenal gland, adult, pool1	10081-102A9	141.87	3.64	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	39.09	24.01	0.67	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	97.19	8.93	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	28.29	19.48	0.93	0.46
amniotic membrane cells, donor2	12236-129G4	73.03	36.52	5.07	0.34
amniotic membrane cells, donor3	12237-129G5	21.21	23.57	0.29	0.00
amygdala - adult, donor10196	10167-103B5	201.59	17.79	2.37	1.19
amygdala, adult, donor10252	10151-102I7	202.56	19.47	3.24	0.41
amygdala, newborn, donor10223	10360-105E9	196.89	10.97	2.26	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	94.73	17.95	2.42	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	181.79	19.64	1.76	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	286.27	10.69	0.00	0.33
aorta, adult, pool1	10052-101G7	74.73	9.22	0.39	0.20
appendix, adult	10189-103D9	112.17	12.03	0.78	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	117.97	5.16	0.34	0.00
artery, adult	10190-103E1	78.80	20.38	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	133.13	17.53	1.16	0.43
b cell line:RPMI1788	10427-106D4	86.25	9.52	1.04	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	109.04	28.30	3.61	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	70.36	20.04	1.89	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	62.93	14.39	2.01	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	69.35	45.86	1.12	0.00
bladder, adult, pool1	10011-101C2	68.44	13.80	0.11	0.22
blood, adult, pool1	10053-101G8	66.44	17.72	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	87.35	17.13	0.00	0.00
bone marrow, adult	10192-103E3	53.31	12.82	0.00	3.37
brain, adult, donor1	10084-102B3	223.46	12.30	1.03	2.05
brain, adult, pool1	10012-101C3	143.54	18.71	1.11	0.33
brain, fetal, pool1	10085-102B4	344.61	18.70	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	110.34	20.81	3.96	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	139.43	23.09	9.24	0.25
breast, adult, donor1	10080-102A8	122.48	10.10	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	181.54	65.93	12.58	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	108.54	11.13	3.40	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	26.01	5.06	0.00	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	96.11	7.02	2.18	0.00
carcinoid cell line:NCI-H1770	10703-109H1	163.15	6.58	4.70	0.47
carcinoid cell line:NCI-H727	10735-110B6	120.87	12.47	2.73	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	155.91	4.44	1.90	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	175.15	6.12	1.60	0.27
caudate nucleus - adult, donor10196	10177-103C6	162.34	16.12	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	178.70	13.05	1.67	1.17
caudate nucleus, adult, donor10258	10379-105H1	211.67	19.87	0.76	1.53
caudate nucleus, newborn, donor10223	10354-105E3	193.74	8.79	2.20	0.00
cerebellum - adult, donor10196	10173-103C2	166.06	37.87	11.65	2.91
cerebellum, adult, donor10252	10166-103B4	172.09	17.72	2.56	1.28
cerebellum, adult, pool1	10083-102B2	137.63	17.25	2.07	0.69
cerebellum, newborn, donor10223	10357-105E6	166.89	17.44	3.32	0.83
cerebral meninges, adult	10188-103D8	161.62	12.61	2.02	0.00
cerebrospinal fluid, donor2	10294-104G6	109.63	14.62	2.19	0.73
cervical cancer cell line:D98-AH2	10552-107I3	64.27	49.75	5.32	0.43
cervical cancer cell line:ME-180	10553-107I4	95.78	43.75	13.09	0.00
cervix, adult, pool1	10013-101C4	80.32	21.73	0.63	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	54.48	7.52	0.98	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	185.49	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	86.99	12.05	3.48	0.25
choriocarcinoma cell line:SCH	10785-110H2	103.01	8.01	3.33	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	94.16	3.56	3.32	0.00
chorionic membrane cells, donor1	12238-129G6	43.31	11.40	0.57	0.28
chorionic membrane cells, donor2	12239-129G7	65.13	9.05	1.19	0.20
chorionic membrane cells, donor3	12240-129G8	37.91	9.34	2.20	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	76.74	98.96	0.00	5.05
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	110.84	32.27	0.96	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	125.23	34.85	0.63	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	49.82	2.82	0.77	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	43.30	5.32	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	50.50	3.46	0.81	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	57.71	5.59	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	113.63	35.71	1.30	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	210.52	29.72	6.17	3.43
clear cell carcinoma cell line:TEN	10636-108I6	96.99	18.39	3.30	0.52
colon carcinoma cell line:CACO-2	10513-107D9	84.57	6.77	2.01	0.18
colon carcinoma cell line:COLO-320	10420-106C6	139.87	11.78	0.76	0.38
colon, adult, donor1	10082-102B1	80.92	14.28	0.00	1.19
colon, adult, pool1	10014-101C5	53.93	12.81	0.47	0.00
colon, fetal, donor1	10070-101I7	129.16	11.12	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	224.59	13.75	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	75.11	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	147.88	14.87	0.85	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	108.07	10.57	0.60	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	115.91	11.28	1.27	0.14
corpus callosum, adult, pool1	10042-101F6	119.08	16.69	1.11	0.55
cruciate ligament, donor2	10295-104G7	72.94	12.97	1.62	1.62
diaphragm, fetal, donor1	10069-101I6	177.37	12.04	0.80	0.00
diencephalon, adult	10193-103E4	118.07	14.16	0.72	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	93.91	22.73	2.53	4.13
ductal cell carcinoma cell line:KLM-1	10438-106E6	55.13	16.16	5.39	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	50.55	9.63	1.20	0.24
ductus deferens, adult	10196-103E7	80.73	27.41	1.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	187.23	5.76	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	93.43	14.71	0.00	2.21
dura mater, adult, donor1	10041-101F5	61.53	15.03	0.25	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	154.34	25.54	3.11	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	182.84	18.77	4.73	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	61.66	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	42.98	1.82	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	65.45	2.16	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	42.03	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	103.24	5.36	1.34	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	66.15	7.79	0.54	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	87.00	8.84	1.77	1.61
epidermoid carcinoma cell line:A431	10426-106D3	110.60	51.36	7.23	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	76.00	22.66	8.58	0.11
epididymis, adult	10197-103E8	91.26	17.37	1.88	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	57.13	4.97	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	84.15	19.27	1.97	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	27.00	8.78	2.62	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	25.79	6.10	1.97	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	31.93	10.42	2.80	0.34
esophagus, adult, pool1	10015-101C6	53.30	20.70	0.53	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	133.75	4.63	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	292.16	31.39	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	187.27	27.35	2.10	0.00
eye - muscle medial, donor2	10299-104H2	360.15	14.88	0.00	0.00
eye - muscle superior, donor2	10297-104G9	254.52	24.08	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	112.22	10.20	0.00	1.46
eye, fetal, donor1	10054-101G9	122.29	19.32	0.51	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	104.76	17.44	1.67	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	92.59	7.83	2.14	0.71
frontal lobe, adult, pool1	10040-101F4	167.38	24.58	1.78	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	109.59	22.22	8.11	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	118.96	20.30	3.47	0.09
gall bladder, adult	10198-103E9	81.36	10.62	0.48	0.00
gamma delta positive T cells, donor1	11937-126A2	62.81	27.38	0.54	1.07
gamma delta positive T cells, donor2	11938-126A3	70.96	22.78	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	34.85	17.74	1.90	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	58.22	8.12	0.77	0.19
gastric cancer cell line:AZ521	10549-107H9	136.08	5.41	0.66	0.16
gastric cancer cell line:GSS	10560-108A2	95.18	3.66	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	110.80	4.11	2.06	2.06
giant cell carcinoma cell line:LU65	10487-107B1	54.39	16.06	1.26	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	143.46	19.87	0.98	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	134.44	15.46	4.99	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	60.06	5.59	1.16	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	70.08	4.92	1.54	0.14
glioblastoma cell line:T98G	10485-107A8	128.36	35.87	5.96	0.22
glioma cell line:GI-1	10413-106B8	81.13	8.79	0.88	0.29
globus pallidus - adult, donor10196	10175-103C4	179.31	16.76	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	135.47	18.06	0.00	1.22
globus pallidus, adult, donor10258	10367-105F7	186.21	8.22	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	185.99	7.46	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	237.37	12.24	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	10.93	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	52.27	20.91	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	92.48	7.04	0.00	1.28
hIPS +CCl2, biol_rep1	14383-156B9	103.76	6.89	1.84	0.00
hIPS +CCl2, biol_rep2	14384-156C1	97.85	6.40	1.37	0.91
hIPS +CCl2, biol_rep3	14385-156C2	110.14	8.37	1.93	0.00
hIPS, biol_rep1	14380-156B6	68.99	12.94	1.44	0.00
hIPS, biol_rep2	14381-156B7	101.51	8.92	0.69	0.69
hIPS, biol_rep3	14382-156B8	101.52	25.38	6.62	2.21
hairy cell leukemia cell line:Mo	10712-109I1	96.55	12.07	2.30	0.86
heart - mitral valve, adult	10205-103F7	79.82	10.46	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	78.18	10.46	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	150.71	19.15	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	85.91	15.10	1.22	0.41
heart, adult, diseased, donor1	10051-101G6	96.24	14.05	0.00	0.85
heart, adult, pool1	10016-101C7	78.65	5.52	0.46	0.46
heart, fetal, pool1	10046-101G1	162.95	8.73	0.41	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	153.64	7.71	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	216.43	4.76	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	110.61	5.97	1.10	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	107.42	9.35	1.46	1.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	106.11	8.59	1.11	0.10
hepatoma cell line:Li-7	10484-107A7	132.46	10.01	1.67	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	116.38	13.27	0.20	0.30
hippocampus - adult, donor10196	10169-103B7	282.01	20.82	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	195.73	14.49	2.45	1.22
hippocampus, adult, donor10258	10374-105G5	113.03	28.88	1.49	0.50
hippocampus, newborn, donor10223	10363-105F3	378.91	14.10	2.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	108.64	7.93	0.61	6.71
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	200.48	5.89	0.59	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	151.07	3.81	0.76	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	341.14	6.77	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	387.58	6.71	0.77	10.84
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	260.41	11.01	1.14	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	190.06	29.20	0.58	2.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	342.96	26.28	3.02	1.94
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	250.66	27.94	2.09	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	182.33	37.65	2.37	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	301.51	32.14	3.54	2.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	207.38	40.40	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	179.17	4.07	1.10	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	152.79	5.40	0.00	6.39
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	80.29	5.24	0.87	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	478.04	9.35	1.53	1.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	396.39	9.16	2.18	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	174.92	8.00	0.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	236.81	11.68	1.32	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	241.45	17.28	1.36	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	224.90	11.28	1.25	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	214.25	15.35	2.29	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	191.31	15.97	1.16	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	191.91	17.94	0.90	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	202.66	5.17	1.11	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	214.25	5.14	2.00	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	128.62	7.76	0.82	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	230.61	7.75	0.70	5.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	296.47	6.65	1.90	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	219.70	7.87	1.82	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	212.54	18.62	3.62	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	225.82	15.94	1.33	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	134.68	19.75	0.77	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	147.00	15.34	1.28	3.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	214.29	27.26	2.27	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	171.05	20.50	0.00	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	214.94	4.83	1.45	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	148.85	4.90	0.00	3.12
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	184.39	5.37	1.46	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	299.51	7.03	2.75	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	110.61	9.76	3.25	22.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	124.10	12.24	0.99	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	281.86	22.99	5.47	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	237.03	24.61	0.36	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	220.28	19.93	3.20	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	238.68	25.06	2.39	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	214.24	41.17	4.06	1.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	210.13	23.71	3.77	1.35
immature langerhans cells, donor1	11904-125F5	37.53	25.18	0.48	0.00
immature langerhans cells, donor2	11905-125F6	38.81	11.88	0.79	0.79
insula, adult, pool1	10039-101F3	179.61	23.85	1.99	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	72.51	28.94	2.93	0.65
kidney, adult, pool1	10017-101C8	75.90	11.41	0.90	0.40
kidney, fetal, pool1	10045-101F9	97.40	9.48	1.06	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	53.40	3.41	0.28	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	45.90	7.74	1.24	1.38
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	56.70	4.95	2.39	0.00
left atrium, adult, donor1	10079-102A7	122.59	11.44	1.09	1.09
left ventricle, adult, donor1	10078-102A6	151.19	9.10	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	242.69	3.28	1.64	0.27
leiomyoma cell line:10964C	10569-108B2	88.02	16.88	3.59	3.23
leiomyoma cell line:15242A	10570-108B3	90.76	28.26	5.98	1.09
leiomyoma cell line:15425	10571-108B4	84.50	17.24	0.97	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	57.14	25.40	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	128.60	9.41	5.23	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	83.82	14.76	0.47	0.12
liposarcoma cell line:KMLS-1	10782-110G8	91.38	17.03	2.66	0.78
liposarcoma cell line:SW 872	10726-110A6	116.11	17.18	4.63	0.37
liver, adult, pool1	10018-101C9	104.69	6.64	0.49	0.32
liver, fetal, pool1	10086-102B5	149.57	4.70	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	209.70	14.44	2.62	0.29
locus coeruleus, adult, donor10252	10165-103B3	152.07	18.09	2.21	1.11
locus coeruleus, adult, donor10258	10375-105G6	231.64	28.21	3.95	2.54
locus coeruleus, newborn, donor10223	10362-105F2	90.01	12.20	4.21	0.00
lung adenocarcinoma cell line:A549	10499-107C4	63.38	11.07	2.63	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	62.74	6.20	3.45	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	83.70	10.55	0.40	0.13
lung, adult, pool1	10019-101D1	53.39	10.28	0.24	0.12
lung, fetal, donor1	10068-101I5	125.29	14.27	2.85	0.57
lung, right lower lobe, adult, donor1	10075-102A3	158.08	11.46	0.92	0.00
lymph node, adult, donor1	10077-102A5	127.81	10.41	1.42	0.95
lymphangiectasia cell line:DS-1	10727-110A7	127.12	7.23	0.22	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	194.70	56.30	3.77	1.21
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	100.24	20.39	3.40	0.00
mature adipocyte, donor1	12231-129F8	51.95	13.76	0.00	0.00
mature adipocyte, donor2	12232-129F9	36.52	8.92	0.00	0.21
mature adipocyte, donor3	12233-129G1	36.51	10.43	0.00	0.24
mature adipocyte, donor4	12234-129G2	33.43	10.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	63.85	3.10	0.95	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	171.46	28.20	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	168.83	20.23	1.66	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	189.34	26.05	1.27	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	73.36	11.09	0.85	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	219.04	15.19	1.18	7.93
medial temporal gyrus, adult, donor10252	10156-103A3	188.88	28.44	3.18	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	132.91	26.97	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	14.35	0.00	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	234.74	17.95	3.23	0.00
medulla oblongata - adult, donor10196	10174-103C3	115.52	10.38	1.95	0.65
medulla oblongata, adult, donor10252	10155-103A2	118.27	11.46	1.24	1.08
medulla oblongata, adult, pool1	10038-101F2	114.11	15.18	1.80	0.24
medulla oblongata, newborn, donor10223	10361-105F1	171.16	11.46	1.04	0.35
medulloblastoma cell line:D283 Med	10838-111E1	131.96	8.41	1.55	1.77
medulloblastoma cell line:ONS-76	10759-110E3	115.30	12.84	4.40	0.12
melanoma cell line:COLO 679	10514-107E1	112.41	20.12	4.60	0.00
melanoma cell line:G-361	10465-106H6	72.75	13.30	4.61	0.00
meningioma cell line:HKBMM	10691-109F7	58.43	9.59	1.09	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	203.55	8.81	2.64	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	172.38	20.74	6.22	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	62.29	11.81	0.31	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	38.17	6.91	0.55	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	43.48	16.15	0.83	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	46.50	12.22	0.70	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	42.94	6.35	0.39	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	72.18	14.58	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	40.51	7.38	0.69	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	51.87	9.43	0.35	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	50.00	9.42	0.40	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	59.96	9.18	0.54	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	50.22	5.12	0.71	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	39.19	6.26	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	54.10	8.30	0.42	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	61.79	10.12	0.00	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	43.90	9.19	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	45.29	5.03	1.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	47.48	5.28	0.10	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	65.43	7.07	2.28	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	62.93	18.04	2.10	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	42.29	7.02	0.30	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	51.91	5.86	0.18	0.61
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	61.85	6.26	0.37	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	54.08	6.01	0.57	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	136.41	24.42	0.84	4.63
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	58.00	14.61	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	60.88	16.88	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	64.39	14.13	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	64.08	11.09	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	56.72	13.42	0.71	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	55.51	20.98	0.00	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	60.12	21.22	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	68.58	14.36	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	66.05	19.90	0.58	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	66.93	19.41	0.45	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	66.34	17.79	0.72	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	65.27	13.93	0.00	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	55.72	23.83	0.34	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	64.27	22.93	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	65.29	18.90	0.43	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	98.44	16.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	66.58	21.44	0.65	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	75.66	17.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	95.95	20.79	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	68.69	23.72	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	86.68	16.33	0.39	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	79.75	14.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	42.72	26.82	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	9.53	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	85.39	18.38	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	71.89	12.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	79.81	15.20	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	70.02	16.21	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	53.73	23.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	23.95	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	41.33	10.33	3.44	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	44.01	9.78	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	52.43	13.51	0.79	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	37.73	8.84	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	51.12	11.22	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	40.10	14.70	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	66.23	10.64	0.00	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	66.77	20.54	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	61.96	11.70	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	75.21	7.92	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	71.78	1.12	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	73.15	6.36	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	107.60	6.85	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	95.95	4.36	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	96.30	1.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	67.36	6.07	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	76.82	13.56	4.52	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	87.31	5.77	1.65	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	80.56	12.90	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	85.67	9.09	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	56.02	6.11	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	39.46	3.09	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	101.35	5.91	2.36	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	156.84	29.89	9.96	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	89.75	59.83	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	60.42	33.09	8.22	1.44
mesothelioma cell line:Mero-25	10850-111F4	122.10	14.53	6.81	1.36
mesothelioma cell line:Mero-41	10851-111F5	97.06	25.18	6.11	1.47
mesothelioma cell line:Mero-48a	10852-111F6	133.97	44.06	19.93	0.44
mesothelioma cell line:Mero-82	10853-111F7	116.69	33.11	7.36	0.79
mesothelioma cell line:Mero-83	10854-111F8	132.43	28.26	15.83	0.34
mesothelioma cell line:Mero-84	10855-111F9	92.52	21.74	3.79	0.25
mesothelioma cell line:Mero-95	10856-111G1	98.55	27.74	10.56	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	93.59	30.98	4.80	0.33
mesothelioma cell line:NCI-H226	10846-111E9	72.22	38.01	6.70	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	85.58	16.06	3.42	0.51
mesothelioma cell line:NCI-H28	10845-111E8	93.90	16.29	2.54	1.27
mesothelioma cell line:No36	10857-111G2	99.49	9.46	7.83	1.63
mesothelioma cell line:ONE58	10858-111G3	94.56	24.93	3.52	1.35
migratory langerhans cells, donor1	11901-125F2	41.65	9.21	0.38	0.77
migratory langerhans cells, donor2	11902-125F3	95.98	15.02	0.85	0.49
migratory langerhans cells, donor3	11903-125F4	80.95	18.31	0.90	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	61.70	4.24	2.94	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	77.78	10.81	0.42	1.91
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	191.20	16.59	3.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	81.64	4.19	0.38	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	139.89	17.56	0.74	0.37
myeloma cell line:PCM6	10474-106I6	75.51	20.36	0.59	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	117.18	25.87	2.03	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	39.82	18.83	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	34.88	7.13	1.67	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	25.96	7.35	0.96	0.00
nasal epithelial cells, donor2	12227-129F4	43.06	13.25	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	172.32	25.54	2.99	0.00
neuroblastoma cell line:NB-1	10539-107G8	242.65	5.05	3.37	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	173.14	7.59	0.84	0.42
neuroblastoma cell line:NH-12	10555-107I6	169.95	14.54	5.96	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	160.84	9.01	2.85	1.66
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	186.89	6.81	1.58	1.27
neuroectodermal tumor cell line:TASK1	10774-110F9	105.86	22.74	4.03	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	295.63	38.15	4.45	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	167.95	14.37	0.53	0.00
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	37.88	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	198.38	8.46	0.85	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	136.09	8.01	2.40	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	128.88	20.52	4.81	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	105.63	24.96	2.36	3.15
nucleus accumbens, adult, pool1	10037-101F1	167.61	19.03	1.59	0.47
occipital cortex - adult, donor10196	10172-103C1	191.62	20.60	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	179.00	22.01	3.76	0.27
occipital cortex, newborn, donor10223	10355-105E4	226.01	12.74	3.64	0.36
occipital lobe, adult, donor1	10076-102A4	342.17	19.94	4.72	0.52
occipital lobe, fetal, donor1	10073-102A1	616.19	28.32	5.15	3.43
occipital pole, adult, pool1	10036-101E9	127.33	11.35	1.66	0.00
olfactory region, adult	10195-103E6	175.77	17.77	1.91	1.15
optic nerve, donor1	10277-104E7	378.20	12.01	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	70.05	17.09	2.85	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	152.50	27.34	4.95	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	43.69	22.01	2.71	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	116.89	33.73	12.71	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	91.72	9.99	1.18	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	71.01	13.08	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	117.90	16.33	1.06	0.42
ovary, adult, pool1	10020-101D2	90.67	13.80	0.35	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	130.71	11.00	1.47	0.37
pancreas, adult, donor1	10049-101G4	119.46	10.35	2.82	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	142.28	7.55	6.99	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	53.32	19.42	6.64	1.70
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	70.37	16.06	0.66	0.00
paracentral gyrus, adult, pool1	10035-101E8	160.53	19.86	2.01	0.37
parietal cortex, adult, donor10258	10373-105G4	99.09	15.41	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	163.64	22.57	0.94	1.88
parietal lobe, adult, donor10252	10157-103A4	159.91	22.52	3.71	1.43
parietal lobe, adult, pool1	10034-101E7	150.16	16.30	1.76	0.35
parietal lobe, fetal, donor1	10072-101I9	402.48	26.19	1.94	2.91
parietal lobe, newborn, donor10223	10356-105E5	173.84	13.09	2.62	0.75
parotid gland, adult	10199-103F1	86.95	13.57	0.00	0.62
penis, adult	10200-103F2	58.01	17.72	0.54	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	113.05	4.09	3.35	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	342.67	77.80	36.42	1.31
pineal gland - adult, donor10196	10179-103C8	225.11	25.80	2.58	0.00
pineal gland, adult, donor10252	10160-103A7	184.77	19.54	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	156.14	23.20	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	185.16	14.17	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	232.45	17.72	1.04	0.00
pituitary gland, adult, donor10258	10378-105G9	200.04	27.24	0.85	0.00
placenta, adult, pool1	10021-101D3	51.60	9.68	1.18	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	92.70	8.87	1.06	1.19
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	65.06	19.14	1.25	0.31
pons, adult, pool1	10033-101E6	121.01	26.25	2.41	0.09
postcentral gyrus, adult, pool1	10032-101E5	147.24	15.17	1.66	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	71.11	8.37	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	33.05	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	145.66	30.15	6.55	0.73
prostate cancer cell line:PC-3	10439-106E7	138.49	16.88	4.72	0.18
prostate, adult, pool1	10022-101D4	75.00	17.41	0.63	0.09
putamen, adult, donor10196	10176-103C5	203.96	13.93	1.89	0.71
putamen, adult, donor10252	10152-102I8	147.05	19.61	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	81.96	14.21	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	143.03	19.33	2.42	0.72
putamen, newborn, donor10223	10365-105F5	71.97	10.50	3.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	53.53	4.95	0.87	0.00
rectum, fetal, donor1	10067-101I4	250.38	23.65	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	120.42	23.74	5.09	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	40.59	4.97	0.41	0.00
retina, adult, pool1	10030-101E3	92.54	14.02	1.29	0.10
retinoblastoma cell line:Y79	10475-106I7	180.82	14.03	1.04	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	131.06	11.19	1.48	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	237.90	14.90	1.41	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	165.21	6.06	0.00	0.00
salivary acinar cells, donor1	11771-123I7	66.04	14.08	1.29	0.65
salivary acinar cells, donor2	11772-123I8	60.44	17.90	1.51	0.83
salivary acinar cells, donor3	11773-123I9	86.73	3.31	1.32	0.66
salivary gland, adult, pool1	10093-102C3	77.79	15.44	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	36.76	6.24	0.51	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	35.85	6.23	0.47	0.35
seminal vesicle, adult	10201-103F3	123.80	22.75	1.59	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	109.32	24.78	9.96	1.70
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	52.34	12.33	0.75	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	75.26	18.06	3.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	101.95	22.70	2.01	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	61.67	8.84	0.88	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	43.22	13.03	0.52	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	194.36	17.02	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	68.12	15.95	0.36	0.00
skeletal muscle, fetal, donor1	10066-101I3	164.82	10.05	0.00	2.01
skin, adult, donor1	10074-102A2	88.21	54.28	6.79	0.00
skin, fetal, donor1	10065-101I2	126.25	22.72	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	208.45	9.01	3.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	128.60	4.10	3.47	2.21
small cell lung carcinoma cell line:DMS 144	10841-111E4	109.48	7.71	0.77	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	123.62	18.13	1.65	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	87.50	1.77	0.00	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	80.19	13.08	1.31	0.44
small intestine, adult, pool1	10024-101D6	48.73	14.57	0.24	0.12
small intestine, fetal, donor1	10064-101I1	87.71	11.79	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	70.78	5.13	1.03	1.03
smooth muscle, adult, pool1	10048-101G3	63.84	12.66	1.03	0.78
somatostatinoma cell line:QGP-1	10781-110G7	132.94	3.75	1.61	0.00
spinal cord - adult, donor10196	10181-103D1	237.21	11.70	0.92	1.38
spinal cord, adult, donor10252	10159-103A6	124.59	9.86	1.18	0.00
spinal cord, adult, donor10258	10369-105F9	43.58	15.91	1.38	1.38
spinal cord, fetal, donor1	10056-101H2	229.91	11.59	3.05	1.83
spinal cord, newborn, donor10223	10359-105E8	63.37	8.73	0.92	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	150.55	16.43	1.49	0.60
spleen, adult, pool1	10025-101D7	62.01	9.58	0.22	0.11
spleen, fetal, pool1	10044-101F8	71.35	9.06	0.16	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	71.73	16.98	1.66	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	34.18	3.23	0.57	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	63.25	17.12	1.40	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	65.68	14.86	2.74	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	47.95	10.02	2.25	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	126.66	21.60	4.24	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	133.69	10.15	1.69	0.00
stomach, fetal, donor1	10062-101H8	278.74	5.34	1.07	0.00
submaxillary gland, adult	10202-103F4	109.38	20.51	0.57	1.14
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	0.00	108.55
substantia nigra, adult, donor10252	10158-103A5	122.75	13.92	1.04	1.25
substantia nigra, adult, donor10258	10371-105G2	89.48	25.35	4.14	1.55
substantia nigra, newborn, donor10223	10358-105E7	163.93	7.07	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	182.27	15.59	2.06	0.69
temporal lobe, adult, pool1	10031-101E4	146.40	12.80	1.44	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	468.67	14.25	3.56	4.27
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	248.78	13.19	1.76	1.76
tenocyte, donor1	11763-123H8	76.80	14.66	0.70	1.75
tenocyte, donor2	11765-123I1	61.04	21.36	1.14	0.38
tenocyte, donor3	11768-123I4	64.13	14.46	0.37	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	131.72	23.11	4.42	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	173.26	4.47	1.23	0.92
teratocarcinoma cell line:PA-1	10807-111A6	190.62	13.02	2.01	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	114.89	11.17	2.29	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	76.39	8.32	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	22.79	6.33	1.20	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	99.34	9.77	3.91	1.30
testis, adult, pool1	10026-101D8	133.68	9.88	1.83	0.75
testis, adult, pool2	10096-102C6	183.59	9.92	3.16	1.35
thalamus - adult, donor10196	10168-103B6	166.70	16.56	3.31	1.10
thalamus, adult, donor10252	10154-103A1	119.87	17.66	0.78	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	137.03	40.03	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	219.04	14.16	2.31	0.33
thalamus, newborn, donor10223	10366-105F6	184.68	24.16	1.73	0.58
throat, adult	10209-103G2	66.66	16.23	0.25	0.75
throat, fetal, donor1	10061-101H7	183.74	13.71	0.91	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	177.07	21.46	1.59	1.59
thymus, adult, pool1	10027-101D9	146.04	21.37	0.99	0.10
thymus, fetal, pool1	10043-101F7	113.67	15.48	1.45	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	55.84	7.05	0.13	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	97.22	8.94	2.93	0.70
thyroid, adult, pool1	10028-101E1	121.03	12.60	0.65	0.28
thyroid, fetal, donor1	10060-101H6	184.56	15.56	1.05	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	178.62	21.56	0.00	0.00
tongue, adult	10203-103F5	64.89	22.56	1.86	0.70
tongue, fetal, donor1	10059-101H5	154.88	19.31	0.00	0.79
tonsil, adult, pool1	10047-101G2	76.13	16.33	1.40	0.40
trachea, adult, pool1	10029-101E2	63.48	17.18	0.57	0.08
trachea, fetal, donor1	10058-101H4	166.19	18.08	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	170.41	27.99	4.61	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	79.74	19.25	2.33	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	206.83	30.87	11.44	0.63
tridermal teratoma cell line:HGRT	10694-109G1	289.18	3.81	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	170.15	18.37	3.05	0.17
umbilical cord, fetal, donor1	10057-101H3	93.89	10.43	2.09	2.09
uterus, adult, pool1	10100-102D1	87.02	19.45	0.68	0.34
uterus, fetal, donor1	10055-101H1	173.03	18.43	0.51	0.00
vagina, adult	10204-103F6	64.62	5.17	0.00	0.00
vein, adult	10191-103E2	88.56	8.77	0.00	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	58.48	6.68	0.53	0.00